Edmond M Kwan

15PUBLICATIONS
82CO-AUTHORS
Radiation therapyPredictive and prognostic markersMolecular targetsCancer geneticsInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 06, 2026
Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Aslı D Munzur, Cameron Herberts, Edmond M Kwan

|May 27, 2025
Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial.

Edmond M Kwan, Sarah W S Ng, Sofie H Tolmeijer

|Apr 25, 2025
p-AKT Protein Expression Predicts Response to AKT Inhibitor Combined with Docetaxel Therapy in Adenocarcinoma and Neuroendocrine Prostate Cancer.

Hipacia Werneck Gomes, Natalie L Lister, Shivakumar Keerthikumar

|Dec 09, 2024
Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer.

Joonatan Sipola, Aslı D Munzur, Edmond M Kwan

|Jan 04, 2024
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping.

Evan W Warner, Kim Van der Eecken, Andrew J Murtha

|Jul 25, 2023
Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate Cancer.

Shikai Fang, Shandian Zhe, Hui-Ming Lin

Pageof 3

Frequent Collaborators

6 joint publications

Alexander W Wyatt

6 joint publications

Arun A Azad

5 joint publications

Cameron Herberts

4 joint publications

Sarah W S Ng